<DOC>
	<DOC>NCT00874237</DOC>
	<brief_summary>The purpose of the present Phase 1 study is to assess the cardiac safety of Staccato Loxapine administered to healthy volunteers in a 3 period crossover study.</brief_summary>
	<brief_title>Staccato Loxapine Thorough QT/QTc</brief_title>
	<detailed_description />
	<mesh_term>Loxapine</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>Subjects who are in good general health and agree to use a medically acceptable and effective birth control method throughout the study. Subjects who have taken prescription or nonprescription medication within 5 days of treatment, Subjects who have had an acute illness within the last 5 days of treatment, Subjects who are smokers, OR Subjects who have an ECG abnormality at baseline.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Staccato loxapine</keyword>
	<keyword>QTc</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>